We report here that activation of protein kinase C (PKC) results in the inhibition of adenovirus virusassociated (VA) gene transcription in vitro. The involvement of PKC in this inhibition is supported by the fact that the addition of PKC inhibitors to transcription reactions in which the PKC cofactor phosphatidyl serine (PS) was present resulted in increased levels of transcription compared to those in reactions in which PKC activity was stimulated in the absence of PKC inhibitors. Furthermore, based on these in vitro studies we propose that the inhibition of VA gene transcription is possibly due to the inability of the VA gene to form an active transcription complex following the activation of PKC. This conclusion was drawn from in vitro data which demonstrated that PS stimulation of endogenous PKC present in cell extracts resulted in failure to isolate a fully initiated, stable transcription complex.
Introduction
The role of protein phosphorylation in adenovirus (Ad) gene regulation has long been inferred because it has been demonstrated that phorbol ester tumour (PET) promoters can modulate transcription from genes in the Ad genome (Fisher et al., 1981; Carter et al., 1987) . Specifically, when Ad-infected (Carter et al., 1984) or Ad-transformed cells (Carter et al., 1987) are treated with the PET promoter 12-O-tetradecanoyl-phorbol-13acetate (TPA), there is accelerated appearance of transcripts from several Ad genes. Since PET promoters can modulate transcription from the Ad genome, it might be argued that protein kinase C (PKC), the receptor for PET promoters, might be involved in the phosphorylation of ancillary transciption factors or other undefined cellular factors which are critical for Ad gene transcription. This is not unreasonable in light of observations which clearly demonstrate that activation of cytoplasmic kinases can lead to phosphorylation events which in turn influence transcription from a number of cellular genes (Chiu et al., 1987; Cantley et al., 1991) . Ultimately, characterization of the effect of phorbol ester on Ad transcription would depend on the identification, isolation and characterization of the cellular factors responsible for modulating the phorbol ester response.
The development of in vitro transcription systems which utilize nuclear or whole cell extracts (WCEs) has made it easier to characterize transcription from a variety of genes. These extracts often contain defined and undefined cellular factors, and they can faithfully transcribe cloned DNA templates of interest. Therefore, we have taken advantage of an in vitro transcription system, using a HeLa WCE prepared as described by Manley et al. (1980) to define the role of PKC in the transcription from a gene in the Ad genome.
In this study, we were particularly interested in attempting to define the effect of PKC on the polymerase III (pol III)-transcribed Ad virus-associated (VA) gene. The transcription of this gene during Ad infection is critical to the translation of viral proteins late in the infection cycle, and VA RNA has also been suggested to play a role in counteracting the antiviral defence of the cell (Thimmappaya et al., 1982) . We report here that under conditions that result in the activation of PKC in HeLa WCEs, there is a reduction in the level of Ad VA gene transcription, and a failure to isolate a stable preinitiation transcription complex. We propose that this inhibition of VA transcription is due to the effect of PKC because the drastic reduction in the number of transcripts from the VA gene observed when PKC was activated in these extracts was prevented by the addition of PKC inhibitors to in vitro transcription reactions.
Methods
Plasmid. The plasmid pLB 45 contains the HindIII B fragment of the Ad-2 genome which spans the VAI and VAII genes. This plasmid was a gift from Lee Babis, Columbia University, N.Y., U.S.A.
Antibody. Anti-PKC, rabbit anti-peptide antibodies were purchased from Gibco BRL. James and T. H. Carter WCE preparation. WCEs from HeLa cells were prepared as described by Manley et al. (1980) , with the exception that all solutions contained 0.5 mM-EGTA.
Assay for PKC activity in WCEs. WCEs, diluted I : 10 in buffer A (20 mM-Tris-HCl pH 7-5 mM-EGTA, 50 mM-2-mercaptoethanol), were loaded on to a l ml diethylaminoethyl cellulose (DE 52) column previously equilibrated in buffer A. The column was then washed with 4 ml of buffer A and 4 ml of buffer B (similar to buffer A with 1 mM-EDTA, 1 mM-EGTA). The fraction containing PKC was eluted in the second wash (0-5 ml per wash) with buffer C (buffer B containing 150 mM-NaCI). The crude preparation of PKC was then assayed to determine the level of histone phosphorylation in the presence of phosphatidyl serine (PS) (Avanti Polar Lipids) prepared by sonication in 20 mM-HEPES pH 7-9. The assay for PKC activity was as follows. Each reaction (40 lal) contained 6.5 mM-HEPES pH 7.6, 10 mM-MgC12, 0.5 mM-EGTA, 1-5 mM-CaClz, 120 ~tM-ATP, 1-25 mg/ml histone HI, 0-5 ~tCi [y-32p]ATP (3000 Ci/mmol), 20 ~tl WCE (PKC source) and 4 ~tl PS or 20 mM-HEPES pH 7-6. The reactions were then incubated at 30 °C for 6 min. The reactions were stopped by the addition of 20 ~tl of 50 mM-EDTA and 5 mM-ATP, spotted on to P81 paper, washed twice for 30 min with 10 mM-H3PO4 and five times with distilled water, rinsed once in 100 ~ ethanol and air-dried. The amount of radioactivity trapped on the dried P81 paper was determined. PKC activity was calculated as the amount of radioactive phosphorus incorporated into histone above the background count, which was the activity in the absence of calcium and phospholipid.
In vitro transcription. Transcription reactions (final volume 20 ~tl) were routinely performed as described by Manley et al. (1980) , using 500 ~tM each of ATP, CTP and GTP, and 5 p.M-UTP, 1-0 p.g/ml a-amanitin and 5 ~tCi [c~-32p]UTP. To determine the effect of PKC on VA gene transcription, PS, prepared as described above, was added to the transcription reactions. The reactions were then incubated at 30 °C for 60 min. The reactions were then processed as previously described (Manley et aL, 1980) to isolate labelled RNA. The purified RNA was dissolved in 20 ~tl denaturation buffer [50~ formamide, 1 × gel buffer (0.1 M-Tris-borate, 2 mM-EDTA pH 8.0)], 0.1 ~ bromophenol blue, 0.01 ~ xylene cyanol and heated at 90 °C for 3 min. Denatured RNA (10 ~tl) was loaded on to a 4~ sequencing gel and electrophoretically separated. The gel was then dried and autoradiographed. For the purpose of quantifying the level of transcription, the area of the gel containing the VA gene transcript was excised and the radioactivity was determined by liquid scintillation spectrophotometry.
Transcription of isolated complex. The method used for the isolation of pol III transcription complex has been described by Culotta et at. (1985) . Briefly, plasmid DNA (1 ~tg/reaction) and WCE were mixed and incubated in the absence of NTPs for 90 rain at 30 °C. The reactions were then centrifuged for 10 min at 4 °C and the invisible pellet was washed three times in extract dialysis buffer. The pellet was resuspended in dialysis buffer (in place of WCE) and elongation of the preformed complex was then facilitated by the addition of NTPs and radioactive UTP as described above. However, where indicated, PS was present during the formation or elongation of the complexes.
Results
In an effort to determine the effect of P K C on the pol IIItranscribed VA gene, we have utilized an in vitro transcription system using HeLa WCE. The success of this approach depended upon whether PKC was present in these preparations of cell extracts, and whether this enzyme is active under the conditions employed. WCE was chosen instead of a nuclear extract because it has been demonstrated that PKC is a cytosolic enzyme (Kraft et al., 1982; Kraft & Anderson, 1983) , and we reasoned that it should be more abundant in WCEs than in nuclear extracts. Confirmation of the presence of PKC in WCEs was obtained from Western blots in which cell extracts were fractionated on SDS-polyacrylamide gels, blotted onto nitrocellulose and reacted with an antiserum which recognized PKC c~, fl and Y isoforms (data not shown), or antiserum which recognized the ~ isoform of PKC ( Fig. 1 a) . Additionally, when WCE was used as the source of PKC there was an increase in histone phosphorylation in the presence of PS, as measured by the amount of radioactive phosphorus incorporated into proteins trapped on P81 paper ( Fig. 1 b) . Furthermore, after PKC activation under conditions identical to those used for in vitro transcription in the presence of [~-32p]ATP, it was observed following P A G E and autoradiography that there was increased incorporation of radioactive phosphorus into several as yet unidentified proteins in WCE when compared to controls in the absence of PS (data not shown). These data established that P K C was present in WCEs and could be activated under transcription conditions. To determine whether transcription of the VA gene can be modulated by P K C in our in vitro transcription reactions, this gene was transcribed in the presence or absence of PS, a cofactor routinely used to activate P K C in in vitro assays. It was observed that in the presence of 200 ~tg/ml PS there was a considerable reduction in VA gene transcription compared to the control reactions (Fig. 2, lanes 3 and 4) . To demonstrate that VA gene transcription was inhibited specifically by PS, phosphatidyl choline (PC) or phosphatidyl ethanolamine (PE), known for their inability to activate P K C (Boni & Rando, 1985) , were added to transcription reactions. Neither PC nor PE had any observable effect on VA gene transcription (Fig. 2, lanes 5 to 16) , an indication that the inhibition was specific for the P K C cofactor, PS. Upon further investigation, it was demonstrated that PS ranging in concentration from 20 ~tg/ml to 200 tlg/ml inhibited VA gene transcription in a dose-dependent manner, with 100 txg/ml to 200 ~tg/ml resulting in the greatest level of inhibition of VA gene transcription (data not shown).
To confirm the involvement of P K C in the inhibition of VA gene transcription, the peptide PKC(19-36) (Gibco BRL), an inhibitor of PKC (House & Kemp, 1987) , or dequalinium (Sigma), an anticarcinoma agent known for its ability to inhibit P K C (Rotenberg et al., 1990) , was added to transcription reactions in the presence or absence of PS. VA gene transcription was reduced by 20% when both PS and the inhibitor PKC(19-36) were present, compared to a 60 to 80% reduction observed under similar conditions but in the absence ofa PKC inhibitor (Fig. 3a, b ). The inhibition of VA gene transcription was also reversed in the presence of 1.0 to 10-0 ktM-dequalinium (Fig. 3c ).
To gain a better understanding of how PKC might regulate transcription from the VA gene, kinetic studies were performed. In these studies, transcription reactions were scaled up and transcription was initiated in the presence or absence of PS. These reactions were sampled at various times and the level of VA gene transcription was determined. From this study, it was determined that during the 60 min incubation period, the level of transcription showed a steady increase when PS was absent from the reactions, whereas in the presence of PS there was little or no increase in VA gene transcription (dat not shown). This observation suggested that transcription of the VA gene was affected at a very early stage in the reaction, possibly at the level of transcription complex assembly or elongation of the fully initiated complex. To test the notion that PS might act at the level C. B. L. James and T. H. Carter of transcription complex formation, DNA and WCE were pre-incubated in the absence of PS and NTPs for various lengths of time to permit the formation of a preinitiated complex. Following this pre-incubation, either NTPs alone or NTPs plus PS were added to permit the elongation of any preformed complexes. The reactions were incubated for an additional 60 min to permit elongation. This approach has been used successfully in studies to define the process of transcription initiation and elongation (Dean & Berk, 1988) . The data revealed that increasing the pre-incubation time, i.e. delaying the addition of PS, resulted in a corresponding increase in levels of transcription once the elongation process was initiated. However, in the control reactions, the level of VA gene transcription was unchanged under similar preincubation and elongation conditions (Fig. 4) . Since preincubation of DNA and WCE could result in the formation of a stable transcription complex, the above data are an indication that increasing the pre-incubation time resulted in the formation of an increasing amount of stable transcription complex, and that this process was inefficient in the presence of PS. The data indicating that PKC might be acting at the level of transcription complex assembly were the impetus for designing the following study utilizing a procedure l~_ I I I I I Fig. 4 . Pre-incubation of VA DNA with WCE overcomes the inhibitory effect of PKC on VA transcription. WCE and DNA were pre-incubated for the times indicated before elongation was initiated by adding NTPs alone or NTPs and PS. Pre-incubation times were set so that elongation could be initiated simultaneously in all tubes. Following this, all reactions were then incubated for an additional 60 min and processed as described in the legend to Fig. 2 . Following autoradiography, the area of the gel containing the labelled VA RNA transcripts was excised and the amount of radioactivity quantified by scintillation spectrophotometry. The results are expressed as relative transcription level, using the control reaction from each time point to represent 10070. The data represented by each bar are the average of reactions done in quadruplicate from a typical experiment. Elongation was then permitted from the isolated complexes (lanes 5 to 16) by the addition of NTPs and dialysis buffer. The reactions were incubated for 60 min to permit elongation from the isolated complexes (final volume was 20 ~tl/reaction), and then processed as described in the legend to Fig. 2 . During the elongation process, PS (200 ktg/ml) was either omitted from ( -) or added to (+) the reactions. In some reactions, elongation of isolated transcription complexes was performed in the presence of cell extract (lanes 11 to 16). Lanes 1 to 4 show control reactions (in duplicate) in the absence (lanes 1 and 2) and presence (lanes 3 and 4) of PS to reflect transcription that was not initiated from preformed isolated complexes.
for the rapid isolation of stable, sedimentable pol III transcription complexes (Culotta et al., 1985) . The procedure involves incubation of supercoiled template DNA and cell extract to form an active transcription complex. In the absence of NTPs there is no elongation of the preformed complex. After a 90 min incubation period, initiated complexes are isolated by centrifugation, washed and the amount of active complex measured by run-off transcription following the addition of NTPs. The generation of radioactively labelled transcript once elongation is allowed to proceed would be indicative of the successful formation of an active, fully initiated transcription complex. By using this protocol, VA gene transcription complexes formed both in the presence and absence of PS were isolated. It was observed that isolated complexes formed in the presence of PS were less active during the elongation process, whereas those formed in the absence of PS were more efficient in generating a transcript of the expected size (Fig. 5, lanes 5 to 8) . In addition, transcription complexes formed in the absence of activated PKC which were then isolated and allowed to elongate in the presence or absence of PS demonstrated no detectable differences in the level of VA gene transcription (Fig. 5, lanes 9 and 10) . This observation indicated that there was a need for soluble factors in WCEs to be present if PS was to have any effect on VA gene transcription. Furthermore, it was indicated that once an active complex was formed and isolated, the addition of WCE and PS had no effect on suppressing transcription from the VA gene (Fig. 5, lanes  13 to 16) . Taken together, these data support the notion that the formation of an active pre-initiation complex and not the elongation process was affected by PKC activation.
Discussion
In the current study we have demonstrated that the capacity of HeLa WCEs to support transcription from the Ad VA gene is reduced following the activation of PKC in these extracts. This conclusion has been reached because the addition of PKC inhibitors to these reactions prevented the drastic reductions in VA gene transcription following the activation of this enzyme. Also, VA gene transcription was increased by approximately 30~ in control reactions when inhibitor was present. This was interpreted to mean that in these WCEs there was residual PKC activity even in the absence of PS activation, and the decrease of this residual enzyme activity by the inhibitor PKC(19-36) allowed for an increase in the basal level of VA gene transcription (see Fig. 3 a) . No such enhancement in the basal transcription level was observed for the inhibitor dequalinium. However, this might be because dequalinium has some non-specific inhibitory action, even on basal levels of transcription from the VA gene template. The role of PKC(19-36) and dequalinium in the inhibition of PKC has been well documented (House & Kemp, 1987; Rotenberg et al., 1990) and they may have other, as yet unknown, stimulatory effects on VA gene transcription by undefined mechanisms. However, based on our data it is reasonable to assume that their main action is the inhibition of PKC following addition to transcription reactions.
From the data provided in this study, it is not clear what the nature and exact modifications of the cellular factors that are affected by the activation of PKC are, hence the molecular mechanism responsible for the inhibition of VA gene transcription is still unclear.
However, there appears to be a block in the assembly of a functional transcription complex. This is supported by the observation that a functional sedimentable transcription complex cannot be demonstrated once PKC has been activated during transcription complex formation. The lack of formation of a transcription complex is further supported by the observation that the inactive complex formed in the presence of activated PKC can give rise to transcripts when replenished with soluble factors in WCE and allowed to elongate (see Fig. 5, lanes  11 and 12) . Therefore, we conclude that, at minimum, the phosphorylation of a cellular factor(s) following the activation of PKC interferes with the assembly of a VA gene transcription complex.
PKC is not a single enzyme, but a family of isoforms with different substrate specificities (Ido et al., 1987) and cofactor requirements for activation (Jaken & Kiley, 1987; Nishizuka, 1988) . This has led to the speculation that different isoforms may control different regulatory pathways within a cell. In the present study, it was observed that the addition of PS in the absence of additional calcium was sufficient to activate PKC activity, which in turn resulted in the inhibition of VA gene transcription. It is important to note that our WCE preparations can be considered calcium-deficient because they were prepared in the presence of EGTA, a reagent used routinely to decrease the level of free calcium and increase the amount of cytosolic PKC. Therefore, it is an intriguing possibility that the inhibition of VA gene transcription observed could be mediated by the action of a PKC isoform which is less dependent on calcium for its activation, e.g. PKC ~.
A number of studies exist which support a role for protein phosphorylation in the initiation and regulation of transcription of a variety of eukaryotic and viral genes. For example, the catalytic subunit of protein kinase A can phosphorylate the CREB protein, which in turn induces transcription from a number of cAMPresponsive genes, including the somatostatin gene (Montminy et aL, 1986; Yamamoto et al., 1988; Gonzales & Montminy, 1989) and the Ad early genes El, E2, E3 and E4 (Hardy & Shenk, 1988) . Furthermore it has been documented that, depending on the state of its phosphorylation, the CREB protein can function as both a positive and a negative regulator (Ofir et al., 1991) . It is evident from the foregoing example that protein phosphorylation of transcription factors could have a dual effect on gene expression.
Virus-encoded products are often required to aid in the modification of cellular factors to create a cellular milieu which is conducive to the transcription of viral genes. Such modifications could involve phosphorylation events. In the case of the pol III-transcribed VA genes, for example, there is enhanced transcription from the Ad VA gene in the presence of the virus-encoded E1A protein (Hoeffler & Roeder, 1985; Hoeffler et al., 1988; Datta et al., 1991) . It is evident from at least one study (Hoeffier et al., 1988 ) that the E1A protein does not change the abundance of the transcription factors required for VA gene transcription, rather it increases the efficiency of transcription by causing an increase in phosphorylation of transcription factor TFIIIC. In addition, other in vitro studies have confirmed that in the absence of additional protein synthesis there could be a change in the level of VA gene transcription (Datta et al., 1991) , thus supporting the notion that modifications such as phosphorylation alone can regulate the level of transcription from this gene. The omission of histone H 1 from the in vitro assay for PKC activity resulted in a threefold reduction of phospholipid-stimulated kinase activity (data not shown), indicating that components of WCE could serve as substrates for phosphorylation by PKC. It is not inconceivable, in light of this observation, that phosphorylation of a transcription factor, or even pol III, could be responsible for modulating the level of transcription from the Ad VA gene following the activation of PKC. It is also equally possible that this inhibition of VA gene transcription is due to the presence of a pre-existing and previously inactive inhibitory cellular factor which has become functional upon phosphorylation by PKC. However, further studies are necessary to distinguish between these possibilities.
Owing to the importance of the E1A protein in enhancing the level of VA gene transcription, it was necessary in this study to consider the effect of this viral protein on VA transcription following PKC activation. It was also necessary to consider this parameter in light of the observation that there is accelerated expression of RNA from the VA genes in Ad-infected cells treated with PET promoters such as TPA (unpublished data). Therefore it was important to determine whether the in vivo data suggest a role for the E1A protein (e.g. for overcoming the block to VA gene transcription following PKC activation). Therefore, transcription of the VA gene was carried out in extracts prepared from 293 cells because these cells are known to express the E 1A protein.
Transcription of the VA gene following the activation of PKC in 293 cell extracts produced results similar to those observed in HeLa WCEs, i.e. PKC activation resulting in the inhibition of VA transcription (not shown). The data suggest that proteins from the E 1 gene alone are not sufficient to overcome the effect of PKC on VA gene transcription. Therefore, the acceleration of VA gene transcription in vivo following TPA treatment could be due to cellular proteins acting in concert with several factors present in infected cells.
This study is a first step towards providing a better understanding of what appears to be a complex set of interactions between Ad and cellular factors following the activation of PKC. Further in vitro analysis should provide additional information which should help to unravel the molecular events responsible for the action of PKC on the regulation of the Ad VA gene.
